Sarah Ketterer

Sarah Ketterer

Last Update: 02-17-2015

Number of Stocks: 79
Number of New Stocks: 8

Total Value: $3,461 Mil
Q/Q Turnover: 19%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Sarah Ketterer Latest Trades these stocks:

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)


This information is for Premium Members Only.

Sarah Ketterer's portfolio and stock picks are for Premium Members only.

If you are a Premium Member, please Log In

If you are not a Premium Member, We invite you for 7-day Free Trial of GuruFocus Premium Membership.

This is just one of the Premium features we provide to Premium Members.

Take the full advantage of Gurus' investment ideas. 7-Day Free Trial Now.

Sarah Ketterer's Profile:

Ms. Ketterer is the Chief Executive Officer of Causeway since June 2001. Her firm manages more than $15 billion as of May, 2008. She is responsible for investment research in global financials and healthcare. Prior Experience From November 1996 to June 2001, Ms. Ketterer worked for the Hotchkis and Wiley division of Merrill Lynch Investment Managers ("HW-MLIM"). At HW-MLIM, she was a Managing Director and co-head of the firm's HW-MLIM International and Global Value team. Education Ms. Ketterer has a BA in Economics and Political Science from Stanford University and an MBA from the Amos Tuck School, Dartmouth College.



Sarah Ketterer's Performance:

Average Annual Return of International Value Fund
5 Yrs Since Inception
3.1% 8.5%
» More Profile & Performance

Sarah Ketterer's Current Portfolio:


Ticker Shares Value ($1000)
Premium0170,199
Premium0168,742
Premium0170,468
Premium0156,779
Premium0153,954
Premium0142,021
Premium0139,820
Premium0133,076
Premium0126,705
Premium0128,614
» More Current Portfolio

Sarah Ketterer's Sector Weightings:


select * from (select sec,round(sum(position),1) as secweight, round(sum(if(impact>0 or null,impact,0)),1) as buyimpact, round(sum(if(impact<0 or NULL, impact,0)),1) as sellimpact from (SELECT round(stock_list.industry/100000,0) as sec , `inst_holdings`.* FROM `inst_holdings`,stock_list where `inst_holdings`.symbol=stock_list.symbol and stock_list.exchange=inst_holdings.exchange and inst_holdings.guru_id = 73 and portdate='2014-12-31' and inst_holdings.verified=1) as a group by sec) as b, (select sector,sectorcode from morn_industry group by sectorcode) as c where b.sec=c.sectorcode order by secweight desc
SectorsSector Weightings (%)
Financial Services 15.4% 15.4%
Healthcare 13.3% 13.3%
Consumer Cyclical 11.2% 11.2%
Technology 11.2% 11.2%
Consumer Defensive 5.7% 5.7%
Energy 4.7% 4.7%
Communication Services 4.5% 4.5%
Industrials 4.1% 4.1%
Basic Materials 3.1% 3.1%
Utilities 0% 0%
» More Sector Weightings

Sarah Ketterer's News:

» More Related News


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Sperrella@facebook
ReplySperrella@facebook - 1 year ago
I like pharm and biotech what about Mannkind and blood labs quest and Bio referrnce? Seems chances for approval are good for Mannkind and next direction for labs are total counseling. Blood tests market is strong w heslthcare opportunities also.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK